Literature DB >> 23103834

Chronic perfusion of angiotensin II causes cognitive dysfunctions and anxiety in mice.

S Duchemin1, E Belanger, R Wu, G Ferland, H Girouard.   

Abstract

High blood pressure is a major risk factor in the onset of cerebrovascular diseases and cognitive impairment. However, mechanisms by which these occur remain unclear and treatments are, therefore, ineffective to prevent cognitive decline related to cardiovascular diseases. Angiotensin II is a peptide involved in the onset and maintenance of hypertension and its effect on cognition was studied acutely but never chronically. Hence, the aim of this study is to evaluate whether chronic hypertensive levels of angiotensin II infusion alter cognitive functions in C57BL6 mice. In this study we used subcutaneous mini-pumps containing a concentration of angiotensin II (1900 ng/kg/min) that induces malignant hypertension or a saline solution for 14 and 21 days. Blood pressure was carefully monitored by a non-invasive tail-cuff method every week throughout the experiment. Spatial memory was assessed using the Morris water maze test and anxiety was measured by the elevated plus maze and the open field tests. The results indicate learning and spatial memory deficit as well as an anxious behavior induced by angiotensin II, in comparison to the vehicle group, starting at the 3rd week of perfusion. The motricity and visual acuity were equivalent in angiotensin II perfused mice compared to their respective control. These results suggest a strong relationship between angiotensin II and the development of cognitive dysfunctions and anxiety along with sustained high blood pressure.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103834     DOI: 10.1016/j.physbeh.2012.10.005

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  16 in total

1.  Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.

Authors:  Jessika Royea; Luqing Zhang; Xin-Kang Tong; Edith Hamel
Journal:  J Neurosci       Date:  2017-05-05       Impact factor: 6.167

2.  Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension.

Authors:  Giuseppe Faraco; Yukio Sugiyama; Diane Lane; Lidia Garcia-Bonilla; Haejoo Chang; Monica M Santisteban; Gianfranco Racchumi; Michelle Murphy; Nico Van Rooijen; Joseph Anrather; Costantino Iadecola
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

3.  Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors.

Authors:  Kelsey M Greathouse; Benjamin W Henderson; Erik G Gentry; Jeremy H Herskowitz
Journal:  Behav Brain Res       Date:  2019-07-11       Impact factor: 3.332

Review 4.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 5.  Is the Brain an Early or Late Component of Essential Hypertension?

Authors:  John Richard Jennings; Matthew F Muldoon; Alan F Sved
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

Review 6.  Vascular cognitive impairment and dementia.

Authors:  Philip B Gorelick; Scott E Counts; David Nyenhuis
Journal:  Biochim Biophys Acta       Date:  2015-12-15

Review 7.  Brain Vasculature and Cognition.

Authors:  Abdelrahman Y Fouda; Susan C Fagan; Adviye Ergul
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

8.  Predator Scent-Induced Sensitization of Hypertension and Anxiety-like Behaviors.

Authors:  Baojian Xue; Jiarui Xue; Yang Yu; Shun-Guang Wei; Terry G Beltz; Robert B Felder; Alan Kim Johnson
Journal:  Cell Mol Neurobiol       Date:  2020-11-17       Impact factor: 5.046

Review 9.  A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Authors:  John W Wright; Leen H Kawas; Joseph W Harding
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-25       Impact factor: 5.555

10.  Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia.

Authors:  A Gadelha; A M Vendramini; C M Yonamine; M Nering; A Berberian; M A Suiama; V Oliveira; M T Lima-Landman; G Breen; R A Bressan; V Abílio; M A F Hayashi
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.